1887

Abstract

In recent decades the incidence of endocarditis has increased dramatically. Despite the application of surgery and antifungal therapy, endocarditis remains a life-threatening infection with significant morbidity and mortality. We report a 37-year-old male drug abuser presenting with high fever, chest pain, loss of appetite and cardiac failure. His echocardiography revealed mobile large tricuspid valve vegetations. Fungal endocarditis was confirmed by culturing of the resected vegetation showing mixed growth of and , although three consecutive blood cultures were negative for species. Phenotypic identification was reconfirmed by sequencing of the internal transcribed spacer (ITS rDNA) region. The patient was initially treated with intravenous fluconazole (6 mg kg per day), followed by 2 weeks of intravenous amphotericin B deoxycholate (1 mg kg per day). Although MICs were low for both drugs, the patient’s antifungal therapy combined with valve replacement failed, and he died due to respiratory failure.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.060954-0
2013-11-01
2019-10-16
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/11/1763.html?itemId=/content/journal/jmm/10.1099/jmm.0.060954-0&mimeType=html&fmt=ahah

References

  1. Athan E., Chu V. H., Tattevin P., Selton-Suty C., Jones P., Naber C., Miró J. M., Ninot S., Fernández-Hidalgo N.. & other authors ( 2012;). Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. . JAMA 307:, 1727–1735. [CrossRef][PubMed]
    [Google Scholar]
  2. Bacak V., Biocina B., Starcevic B., Gertler S., Begovac J.. ( 2006;). Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient–case report and review of literature. . J Infect 53:, e11–e14. [CrossRef][PubMed]
    [Google Scholar]
  3. Baddley J. W., Benjamin D. K. Jr, Patel M., Miró J., Athan E., Barsic B., Bouza E., Clara L., Elliott T.. & other authors ( 2008;). Candida infective endocarditis. . Eur J Clin Microbiol Infect Dis 27:, 519–529. [CrossRef][PubMed]
    [Google Scholar]
  4. Barrau K., Boulamery A., Imbert G., Casalta J. P., Habib G., Messana T., Bonnet J. L., Rubinstein E., Raoult D.. ( 2004;). Causative organisms of infective endocarditis according to host status. . Clin Microbiol Infect 10:, 302–308. [CrossRef][PubMed]
    [Google Scholar]
  5. Daas H., Abuhmaid F., Zervos M.. ( 2009;). Successful treatment of Candida parapsilosis and Pseudomonas aeruginosa infection using medical and surgical management in an injecting drug user with mitral and aortic valve endocarditis: a case report. . J Med Case Reports 3:, 6598. [CrossRef][PubMed]
    [Google Scholar]
  6. Jain D., Oberoi J. K., Shahi S. K., Shivnani G., Wattal C.. ( 2011;). Scopulariopsis brevicaulis infection of prosthetic valve resembling aspergilloma on histopathology. . Cardiovasc Pathol 20:, 381–383. [CrossRef][PubMed]
    [Google Scholar]
  7. Jiang C., Dong D., Yu B., Cai G., Wang X., Ji Y., Peng Y.. ( 2013;). Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. . J Antimicrob Chemother 68:, 778–785. [CrossRef][PubMed]
    [Google Scholar]
  8. Kumar P., Muranjan M. N., Tullu M. S., Vaideeswar P., Kher A., Lahiri K. R.. ( 2010;). Candida tropicalis endocarditis: Treatment in a resource-poor setting. . Ann Pediatr Cardiol 3:, 174–177. [CrossRef][PubMed]
    [Google Scholar]
  9. Melamed R., Leibovitz E., Abramson O., Levitas A., Zucker N., Gorodisher R.. ( 2000;). Successful non-surgical treatment of Candida tropicalis endocarditis with liposomal amphotericin-B (AmBisome). . Scand J Infect Dis 32:, 86–89. [CrossRef][PubMed]
    [Google Scholar]
  10. Millar B. C., Moore J. E.. ( 2004;). Current trends in the molecular diagnosis of infective endocarditis. . Eur J Clin Microbiol Infect Dis 23:, 353–365. [CrossRef][PubMed]
    [Google Scholar]
  11. Millar B. C., Moore J. E., Mallon P., Xu J., Crowe M., Mcclurg R., Raoult D., Earle J., Hone R., Murphy P.. ( 2001;). Molecular diagnosis of infective endocarditis–a new Duke’s criterion. . Scand J Infect Dis 33:, 673–680. [CrossRef][PubMed]
    [Google Scholar]
  12. Millar B. C., Jugo J., Moore J. E.. ( 2005;). Fungal endocarditis in neonates and children. . Pediatr Cardiol 26:, 517–536. [CrossRef][PubMed]
    [Google Scholar]
  13. Moreillon P., Que Y. A.. ( 2004;). Infective endocarditis. . Lancet 363:, 139–149. [CrossRef][PubMed]
    [Google Scholar]
  14. Nadir E., Rubinstein E.. ( 2004;). Fungal endocarditis. . Curr Infect Dis Rep 6:, 276–282. [CrossRef][PubMed]
    [Google Scholar]
  15. Nahass R. G., Weinstein M. P., Bartels J., Gocke D. J.. ( 1990;). Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients. . J Infect Dis 162:, 967–970. [CrossRef][PubMed]
    [Google Scholar]
  16. Oz Y., Kiremitci A., Dag I., Metintas S., Kiraz N.. ( 2013;). Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates. . Med Mycol 51:, 60–65. [CrossRef][PubMed]
    [Google Scholar]
  17. Pierrotti L. C., Baddour L. M.. ( 2002;). Fungal endocarditis, 1995-2000. . Chest 122:, 302–310. [CrossRef][PubMed]
    [Google Scholar]
  18. Prendergast B. D.. ( 2006;). The changing face of infective endocarditis. . Heart 92:, 879–885. [CrossRef][PubMed]
    [Google Scholar]
  19. Rajendram R., Alp N. J., Mitchell A. R., Bowler I. C., Forfar J. C.. ( 2005;). Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement. . Clin Infect Dis 40:, e72–e74. [CrossRef][PubMed]
    [Google Scholar]
  20. Saito Y., Takahashi M., Sato A., Katsuki T., Ikeda U., Shimada K.. ( 2001;). Isolated tricuspid valve endocarditis due to Candida parapsilosis associated with long-term central venous catheter implantation. . Intern Med 40:, 403–404. [CrossRef][PubMed]
    [Google Scholar]
  21. Sousa C., Botelho C., Rodrigues D., Azeredo J., Oliveira R.. ( 2012;). Infective endocarditis in intravenous drug abusers: an update. . Eur J Clin Microbiol Infect Dis 31:, 2905–2910. [CrossRef][PubMed]
    [Google Scholar]
  22. Talarmin J. P., Boutoille D., Tattevin P., Abgueguen P., Ansart S., Roblot F., Raffi F.. ( 2009;). Candida endocarditis: role of new antifungal agents. . Mycoses 52:, 60–66. [CrossRef][PubMed]
    [Google Scholar]
  23. Wang’ondu R. W., Murray T. S.. ( 2011;). Relapse of polymicrobial endocarditis in an intravenous drug user. . Yale J Biol Med 84:, 321–324.[PubMed]
    [Google Scholar]
  24. White T. J., Bruns T., Lee S., Taylor J.. ( 1990;). Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. . In PCR Protocols: a Guide to Methods and Applications, pp. 315–322. Edited by Innis M. A., Gelfand D. H., Sninsky J. J., White T. J... New York:: Academic Press;.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.060954-0
Loading
/content/journal/jmm/10.1099/jmm.0.060954-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error